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1
Introduction
There are an estimated 2.1 million e-cigarette users in Great Britain.1 
Among smokers, 50.6% have ever used e-cigarettes, 17.6% cur-
rently use e-cigarettes, current use among former smokers is lower, 
estimated at 4.5%, and use among nonsmoking adults is estimated 
at 0.2%.1
E-cigarettes use battery power to heat an element to disperse a 
solution that usually contains nicotine.2 The dispersion of the solu-
tion leads to the creation of an aerosol that can be inhaled by the 
user. The heated solution typically contains propylene glycol or 
glycerine, water, nicotine, and flavorings. E-cigarettes do not con-
tain tobacco, do not create smoke and do not rely on combustion. 
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Abstract
Introduction: E-cigarettes can be categorized into two basic types, (1) cigalikes, that are disposable 
or use pre-filled cartridges and (2) tanks, that can be refilled with liquids. The aims of this study 
were to examine: (1) predictors of using the two e-cigarette types, and (2) the association between 
type used, frequency of use (daily vs. non-daily vs. no use), and quitting.
Methods: Online longitudinal survey of smokers in Great Britain was first conducted in November 
2012. Of 4064 respondents meeting inclusion criteria at baseline, this study included (N = 1643) current 
smokers followed-up 1 year later. Type and frequency of e-cigarette use were measured at follow-up.
Results: At follow-up, 64% reported no e-cigarette use, 27% used cigalikes, and 9% used tanks. 
Among e-cigarette users at follow-up, respondents most likely to use tanks versus cigalikes 
included: 40–54 versus 18–24  year olds and those with low versus moderate/high education. 
Compared to no e-cigarette use at follow-up, non-daily cigalike users were less likely to have quit 
smoking since baseline (P =  .0002), daily cigalike or non-daily tank users were no more or less 
likely to have quit (P = .3644 and P = .4216, respectively), and daily tank users were more likely to 
have quit (P = .0012).
Conclusions: Whether e-cigarette use is associated with quitting depends on type and frequency 
of use. Compared with respondents not using e-cigarettes, daily tank users were more likely, and 
non-daily cigalike users were less likely, to have quit. Tanks were more likely to be used by older 
respondents and respondents with lower education.
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Consequently, they can deliver nicotine to the user with lower expo-
sure to the harmful constituents that are produced by combustion 
of ordinary tobacco cigarettes.3 Several concerns and possible ben-
efits of e-cigarettes have been discussed in the public health com-
munity. Concerns include use by youth, renormalization of smoking, 
deterring smoking cessation, and adverse health effects; while there 
is optimism about their use as a smoking cessation aid, and their 
potential to serve as a less harmful nicotine product for smokers.4
There is substantial heterogeneity between different types of 
e-cigarettes and the speed with which they are evolving making 
them difficult to categorize. E-cigarettes available in the United 
Kingdom can be classified into two basic types: (1) “cigalikes,” 
often resembling tobacco cigarettes, both disposable or with 
pre-filled cartridges and (2) “tanks,” designed to be refilled with 
liquid.2,5 In the United Kingdom, many of the most widely sold 
brands of cigalikes are now owned by the tobacco industry.6 To the 
authors’ knowledge, only one tobacco company owned e-cigarette 
company currently sells a tank model that is designed to be refilled 
with liquids by the user in the United Kingdom7; of note is that this 
company does not currently sell tanks in the United States that the 
authors are aware of.
Studies have validated the ability of e-cigarettes to deliver nico-
tine to the user. Blood plasma nicotine concentrations increase after 
inhalation of e-cigarette aerosol5,8 and cotinine, a biomarker for 
nicotine, has been detected in the saliva of e-cigarette users.9,10 The 
dose and rate at which an e-cigarette delivers nicotine to the user 
under fixed conditions, specifically, the nicotine per puff second, has 
been referred to as “nicotine flux.”11,12 Differences have also been 
found in the nicotine content of the aerosol within and across e-cig-
arette brands and liquids.13–15 There is also evidence that nicotine 
delivery differs by user, with more experienced users being able to 
obtain greater nicotine delivery, sometimes equivalent to ordinary 
tobacco cigarettes.8,16,17 This variation in user behavior has recently 
been attributed to puff duration, with longer puff duration leading 
to greater nicotine delivery.18 In addition to nicotine, differences 
have been found in the levels of carbonyl compounds in e-cigarette 
aerosol, such as formaldehyde.19 Tanks with variable voltage have 
also been shown to produce an aerosol with a greater concentration 
of carbonyl compounds when used at a higher voltage.20 However, 
recent commentary has raised problems with these studies, including 
that higher voltage levels would be aversive/unpalatable to users in 
real conditions.21
Because e-cigarettes have the ability to deliver nicotine there is a 
potential mechanism for e-cigarettes to function as a quitting aid.22 
However, depending on the “nicotine flux” of an e-cigarette, some 
e-cigarette products and brands may be less effective than others for 
quitting, such that too little nicotine flux may not provide sufficient 
nicotine replacement for a smoker to quit, and too much may be 
unappealing if it causes side effects, such as nausea.11,12 One study 
comparing nicotine delivery among e-cigarette product types found 
that a popular tank model delivered more nicotine than a popular 
brand of cigalike.23 Another study found that inexperienced e-cig-
arette users rated cigalikes as less satisfying, but found no differ-
ences between cigalikes and tanks in relieving urges to smoke or 
withdrawal symptoms.24 If cigalikes deliver less nicotine than tanks 
given a fixed-type of user behavior, and are less satisfying to users in 
other ways, it is possible that they may be less effective for promot-
ing smoking cessation.
Research also suggests that the types of e-cigarette products used 
by smokers and ex-smokers differ. Among a cross-sectional sample 
of 19 000 e-cigarette users from multiple countries,25 e-cigarette 
users who used cigalikes were less likely to be former smokers 
than those using tanks. Additionally, cross-sectional data show that 
among e-cigarette users, ex-smokers were more likely than current 
smokers to use tanks (54% vs. 35%).1
Studies using longitudinal data have examined the association 
between e-cigarette use and smoking cessation. However, to the 
authors’ knowledge, none of these studies have taken into account 
type of e-cigarette used, and only two have considered frequency 
of use. A study from Australia, Canada, United States, and United 
Kingdom found that e-cigarette users at follow-up were more 
likely to have reduced their cigarette consumption from 1 year ear-
lier, but were not more likely to have quit.26 A web-based US study 
found that e-cigarette use at baseline did not prospectively predict 
smoking cessation 1 year later or lead to a reduction in cigarette 
consumption.27 Neither of the above studies considered frequency 
of use or type of e-cigarette. A longitudinal survey of established 
e-cigarette users, recruited from online e-cigarette user communi-
ties and smoking cessation websites, found that e-cigarette use was 
associated with reduced cigarette consumption.28 The two stud-
ies that have considered frequency of e-cigarette use have found 
differences in smoking behavior between more and less frequent 
users. Brose et al.29 found that respondents who used e-cigarettes 
daily at baseline were more likely to have made a quit attempt 
1 year later, but were no more or less likely than those who did not 
use e-cigarettes to quit; daily e-cigarette use at follow-up was also 
associated with reduced cigarette consumption since baseline; no 
effects of non-daily e-cigarette use on quit attempts, quitting, or 
cigarette consumption were found. A study of 695 smokers from 
the United States found that those who reported using e-cigarettes 
daily for at least a month were more likely to have quit at follow-
up, compared no use.30
Other studies have also examined the association between e-cig-
arette use and smoking cessation. In a cross-sectional study of 5863 
English smokers who attempted to quit in the past year without using 
professional support, Brown et al.31 found that respondents who used 
e-cigarettes on their last quit attempt compared to over-the-counter 
nicotine replacement therapy or no quit aid were more likely to 
report abstinence.31 Two randomized control trials have also tested 
the efficacy of cigalike type e-cigarettes for smoking cessation. Bullen 
et al.32 found that e-cigarettes with or without nicotine were compa-
rable to nicotine replacement therapy patches in supporting absti-
nence among smokers wanting to quit. Caponnetto et al.33 compared 
use of e-cigarettes among three groups of smokers not intending to 
quit (N  =  300): with nicotine (7.2 mg), with nicotine (7.2 mg) but 
reducing nicotine over the study period (5.4 mg), and nicotine-free. 
Caponnetto et  al.33 found no differences among the three groups, 
with all groups showing similar declines in cigarette consumption 
and quitting, with an overall abstinence rate of 8.7% at 52 weeks.
To fill gaps in the current research on e-cigarettes and smok-
ing cessation, this study aimed to investigate (1) baseline predictors 
of using cigalikes versus tanks among e-cigarette users at a 1-year 
follow-up and (2) the cross-sectional association between type of 
e-cigarette used, frequency of e-cigarette use, or no e-cigarette use 
at all and smoking cessation at follow-up, adjusting for baseline 
characteristics. Information on e-cigarette type was only collected 
at follow-up so it was not possible to examine the association with 
baseline data. These research questions were investigated using 
a web-based longitudinal (2012–2013) sample of adult smokers 
at baseline in Great Britain drawn from the general population. 
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The baseline sample was previously described in a publication by 
Brown et al.34
Methods
Design
This study drew respondents from a longitudinal sample of smok-
ers and ex-smokers recruited from an online panel managed by 
Ipsos MORI. Members of the online panel were invited by email 
to participate in a survey about smoking. Compensation for 
participation included points that could be used for high street 
vouchers or entry into a draw for prizes. Between November and 
December 2012, 23 785 respondents accepted the invitation and 
were asked a screening question about their smoking status of 
whom 25.9% (n = 6165) qualified for because they smoked in the 
past year; quotas were imposed to ensure broad representative-
ness by sex, age, and region. The proportion of past-year smok-
ing was similar to a nationally representative sample of English 
smokers from a face-to-face survey.35 Of the 6165 respondents 
who met the inclusion criteria, N  =  5000 fully completed the 
baseline survey. The follow-up survey was conducted 1 year later 
in December 2013 with an overall follow-up rate for the entire 
sample of 43.6% (n  =  2182). The present study included cur-
rent smokers only at baseline (n = 4064), of whom (n = 1759), 
were successfully followed-up (43.3%). Respondents who did not 
know their smoking status or reported they were exclusive users 
of other types of tobacco at follow-up were excluded in the final 
analysis, along with respondents with missing data or don’t know 
responses on key variables (n = 116), resulting in a final sample 
size of (n = 1643).
Measures
Demographics and Smoking Behavior
Demographics at Baseline. Measures included gender (male vs. 
female), age (18–24, 25–39, 40–54, and 55+), highest level of edu-
cation, and annual household income. Education was categorized 
as: low = primary or secondary school/vocational level 1 & 2/trade 
apprenticeship, secondary school advanced/vocational level 3; mod-
erate = further education/training college below degree level, or some 
university; and high = at least a university degree. Income was cat-
egorized as: low = under £30 000, moderate = £30 000–£44 999, 
high ≥ £45 000, and “no answer” (due to a high number of don’t 
knows/prefer not to say responses).
Smoking Status at Baseline and Follow-up. Respondents were 
asked, “Which of the following best applies to you?” I smoke ciga-
rettes (including hand-rolled) every day, I smoke cigarettes (including 
hand-rolled) but not every day, I do not smoke cigarettes at all but 
I do smoke tobacco of some kind (eg, pipe or cigar), I have stopped 
smoking completely in the last year, I stopped smoking completely 
more than a year ago, or don’t know/couldn’t say. Respondents who 
said at baseline they currently smoked cigarettes daily or non-daily 
were included in this study. At follow-up, ex-smokers were defined 
as having stopped smoking.
Strength of Urges to Smoke at Baseline. Strength of urges to smoke 
(SUTS) at baseline was used as a measure of cigarette dependence; 
SUTS has been demonstrated to be a reliable predictor of short-term 
quitting among English smokers.36 Respondents were asked: “How 
much of the time have you felt the urge to smoke in the past 24 
hours?” with responses: not at all, a little of the time, some of the 
time, a lot of the time, almost all of the time, all of the time, or don’t 
know. Respondents who felt urges to smoke were then asked: “In 
general, how strong have the urges to smoke been?” with responses: 
slight, moderate, strong, very strong, extremely strong, or don’t 
know. “Not at all” responses to the first question were coded as 0, 
and responses from the second question made up the remainder of 
the scale leading to a final measure of 0 (no urges) to 5 (extremely 
strong urges). Don’t know responses were excluded.
Motivation to Stop Smoking at Baseline. Motivation to stop smok-
ing at baseline (MTSS) has been shown to predict quit attempts 
among English smokers.37 Smokers were asked: “Which of the fol-
lowing best describes you?” with responses: I REALLY want to stop 
smoking and intend to in the next month, I REALLY want to stop 
smoking and intend to in the next 3 months, I want to stop smok-
ing and hope to soon, I REALLY want to stop smoking but I don’t 
know when I will, I want to stop smoking but haven’t thought about 
when, I think I should stop smoking but don’t really want to, I don’t 
want to stop smoking, or don’t know. MTSS was dichotomized into 
those having motivation to stop in a defined time frame (in the next 
month, or 3 months) versus otherwise.
E-cigarette Measures
E-cigarette Use at Baseline and Follow-up. If respondents had heard 
of and tried an electronic cigarette, they were asked, “How often, if 
at all, do you currently use an electronic cigarette?”: daily, less than 
daily but at least once a week, less than weekly but at least once a 
month, less than monthly, not at all, or don’t know. Don’t know 
responses were coded as nonusers. For analyses that separated daily 
versus non-daily e-cigarette users, the variable was recoded as: daily 
use versus less than daily but at least once a week, less than weekly 
but at least once a month, or less than monthly.
E-cigarette Type at Follow-up. Respondents who used e-cigarettes 
less than monthly or more often were asked what type of electronic 
cigarette equipment they currently use the most. Response categories 
included: (1) disposable electronic cigarette (non-rechargeable), (2) a 
commercial electronic cigarette kit which is refillable with pre-filled 
cartridges, (3) a commercial electronic cigarette kit which is refill-
able with liquids, or (4) a modular system (I use my own combina-
tion of separate devices: batteries, atomizers, etc.). E-cigarette type 
was dichotomized into: cigalike, categories (1) and (2) versus tank, 
categories (3) and (4). Because data on current e-cigarette brand/
model used most often was also collected, brand and type were cross 
checked to ensure our categorization was correct. E-cigarette type 
was changed to match brand/model in 27 cases (5%) where brand 
and type did not match using the brand data.
E-cigarette Type and Frequency of Use at Follow-up. A measure was 
derived from the questions on e-cigarette use and type of e-cigarette 
used at follow-up: no e-cigarette use, non-daily use of cigalike, daily 
use of cigalike, non-daily use of tank, daily use of tank.
Analyses
SAS 9.3 was used for all analyses. An attrition analysis was con-
ducted to examine differences between respondents who were eligi-
ble at baseline and respondents who were successfully followed-up 
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with versus lost to attrition using Pearson chi-square analyses. For 
the main analyses, predictors of type of e-cigarette used at follow-
up were first examined. Bivariate and multivariable logistic regres-
sion analyses were used to examine predictors of type of e-cigarette 
used at follow-up (tank vs. cigalike) among the 587 e-cigarette users 
at follow-up. Predictors examined included: gender, age, education, 
income, SUTS, and MTSS at baseline, and any use of e-cigarettes at 
baseline (less than monthly or more often vs. not at all). Any use of 
e-cigarettes at baseline was adjusted for because longer-term e-ciga-
rette users (eg, those using at baseline and follow-up) may be more 
likely to use tanks.1 Additionally, because more frequent e-cigarette 
users may be more likely to use tanks, a sensitivity analysis was con-
ducted by adding frequency of e-cigarette use at follow-up (daily vs. 
non-daily) into the model as a control variable to test whether the 
significant predictors of type of e-cigarette use changed. The asso-
ciation between e-cigarette type and frequency of e-cigarette use at 
follow-up and quitting smoking since baseline was then examined 
among the longitudinal sample (N = 1643). Smoking status at fol-
low-up (ex-smoker vs. smoker) was set as the dependent variable in 
a multivariable logistic regression analysis adjusting for gender, age, 
education, income, SUTS, MTSS, and any e-cigarette use at baseline, 
with e-cigarette type and frequency of use at follow-up as the main 
independent variable of interest.
Results
Sample Characteristics and Attrition
Key demographic sample characteristics are shown in Table  1. 
Notable sample characteristics include the larger proportion of males 
(56.66%), and the high number of low income respondents (57.09% 
with annual household income under £30 000). Respondents who 
were followed up were significantly more likely at baseline to be 
male (P < .0001), from older age groups (P < .0001), have lower 
education (P = .0002), and have no motivation to quit in the next 
3 months (MTSS; P = .0013); no differences were found by income 
(P = .1326), SUTS (0.1515), or e-cigarette use (P = .1318). Because 
e-cigarette type was only assessed at follow-up this prevented attri-
tion analyses on this key variable. At follow-up, 64% reported no 
e-cigarette use, 27% used cigalikes, and 9% used tanks.
Predictors of E-cigarette Product Type
Of the 587 e-cigarette users, 448 used cigalikes (76.32%) and 139 
(23.68%) used tanks. Bivariate analyses showed that at follow-up 
the following groups were more likely to use tanks versus cigalikes: 
40–54 year olds versus 18–24 year olds, and respondents with low 
versus moderate or high education. Gender, income, SUTS, MTSS, 
and e-cigarette use at baseline did not predict tank versus cigalike 
use at follow-up (Table 2). The multivariable analysis that adjusted 
for all variables that were examined in bivariate analyses produced 
similar results, with no changes in the comparisons that were sig-
nificant at P < .05. A sensitivity analysis that added a control vari-
able for frequency of e-cigarette use at follow-up did not lead to 
any changes in the baseline predictors of type of e-cigarette use at 
follow-up that were significant at P < .05. However, frequency of use 
at follow-up was associated with type of e-cigarette used at follow-
up, such that, daily e-cigarette users at follow-up had 3.46 times 
greater odds of using tanks (35.94%) compared to non-daily users 
(17.72%) (95% CI =1.89% to 6.32%, P < .0001).
E-cigarette Product Type, Frequency of Use, and 
Smoking Cessation
Multivariable analyses showed that quitting smoking since base-
line was associated with frequency and type of e-cigarette used at 
follow-up (Table  3). Adjusting for other factors that predict quit-
ting, compared to respondents who reported no e-cigarette use at 
follow-up: respondents who used cigalikes non-daily were less likely 
to have quit, respondents who used cigalikes daily were no more 
or less likely to have quit, respondents who used tanks non-daily 
were no more or less likely to have quit, and respondents who used 
tanks daily were more likely to have quit. Baseline factors that pre-
dicted quitting included income, MTSS, and SUTS. Smokers who 
had higher incomes versus lower incomes, experienced weaker urges 
to smoke, and were motivated to stop smoking in the next 3 months 
at baseline were more likely to have quit at follow-up.
Discussion
In a sample of smokers at baseline, predictors of using tanks versus 
cigalikes at a 1-year follow-up included low versus moderate and 
high education, and middle (40–54) versus younger age (18–24). 
Daily e-cigarette users at follow up were also more likely to use 
tanks than non-daily users. This study additionally found that when 
adjusting for baseline factors that predict quitting, there was a cross-
sectional association between type and frequency of e-cigarette used, 
and quitting smoking at follow-up. Compared with respondents not 
using e-cigarettes at follow-up, respondents who were using a tank 
e-cigarette daily were more likely to have quit. Respondents using 
tanks non-daily or a cigalike daily were no more or less likely to 
have quit, while those using cigalikes non-daily were less likely to 
have quit.
This is the first longitudinal study drawn from a general popula-
tion sample to examine the association between quitting smoking 
and type and frequency of e-cigarette use. Because different asso-
ciations were found depending on type and frequency of e-cigarette 
use, this study suggests that it is important to consider type and fre-
quency of e-cigarette use when examining the association between 
e-cigarette use and quitting smoking.
The findings of this study are similar to previous studies that have 
suggested that people using tanks are more likely to be ex-smokers.25,38 
Table 1. Key Demographic Sample Characteristics (N = 1643)
Variable N %
Gender
 Male 931 56.66
 Female 712 43.34
Age
 18–24 164 9.98
 25–39 459 27.94
 40–54 528 32.14
 ≥55 492 29.95
Education
 Low 571 34.75
 Medium 641 39.01
 High 431 26.23
Income
 Low 938 57.09
 Medium 379 23.07
 High 180 10.96
 No answer 146 8.89
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Additionally, the findings that those who use e-cigarettes more fre-
quently (daily vs. non-daily) are more likely to quit, are similar to 
findings by Biener and Hargraves30 who found that it was only more 
intensive e-cigarette use that predicted quitting compared to no use, 
and Brose et  al.29 who found that only daily e-cigarette users were 
more likely to have reduced their cigarette consumption and made quit 
attempts. It is also worth noting that the association between more 
intensive e-cigarette use and quitting is similar to findings that suggest 
that greater adherence to nicotine replacement therapy may predict 
quit success.39,40 Additionally, similar to previous studies in other sam-
ples of English smokers, motivation to stop smoking, weaker urges to 
smoke (a measure of nicotine dependence), and higher income (an indi-
cator of socioeconomic status), predicted quitting in this study.36,37,41 
The fact that these variables still predicted quitting after adjusting for 
frequency and type of e-cigarette use suggest that e-cigarettes did not 
close the gap in inequities in quitting in this sample. Further research 
should investigate the impact of e-cigarettes on quitting for groups that 
have been found to be less likely to successfully quit (more nicotine 
dependent, and lower socioeconomic status).41,42
These findings, showing an association between e-cigarette type, 
frequency of use, and quitting, should be considered in the context 
of the e-cigarette regulatory environment. For example, they may be 
particularly relevant due to calls by the tobacco industry for strin-
gent regulations for tanks in the United States (along with the fact 
that, to the authors’ knowledge, that most tobacco companies sell 
only cigalikes), and restrictions on tank type e-cigarettes in some 
healthcare settings.43–45
This study has several limitations. A low follow-up rate of 43.3% 
and differential loss to follow-up mean that the findings may not 
apply to all groups. Because e-cigarette type was only assessed at 
follow-up, we were unable to ascertain if there was differential loss 
to follow-up by e-cigarette type and frequency of use. Additionally, 
although efforts were made to ensure the representativeness of the 
sample at baseline, this was not a nationally representative survey, 
and caution should be taken when applying the results to the gen-
eral population, particularly given the low follow-up rate. The data 
were also self-reported. Additionally, because e-cigarette type and 
frequency of use was measured at follow-up conclusions cannot be 
made about whether use is predictive of later cessation because the 
direction of causation might be reversed. For example, it could be 
that there is no association between e-cigarette type and quitting, 
and instead that established e-cigarette use, using a tank model, 
Table 2. E-cigarette Users: Baseline Predictors of Using a Cigalike Versus Tank E-cigarette at Follow-up (N = 587)a
Variable
Bivariate Multivariable
N % using tank ORb LCI UCI P OR LCI UCI P
Gender
 Male 309 22.33 1.00 1.00 1.00 ref 1.00 1.00 1.00 ref
 Female 278 25.18 1.17 0.80 1.71 .4176 1.12 0.75 1.67 .5744
Age
 18–24 56 14.29 1.00 1.00 1.00 ref 1.00 1.00 1.00 ref
 25–39 183 19.67 1.47 0.64 3.38 .3649 1.77 0.75 4.16 .1900
 40–54 188 27.66 2.29 1.02 5.18 .0455 2.41 1.05 5.52 .0378
 ≥55 160 26.88 2.21 0.97 5.04 .0606 2.16 0.92 5.08 .0774
Education
 Low 187 33.69 1.00 1.00 1.00 ref 1.00 1.00 1.00 ref
 Moderate 233 22.32 0.57 0.37 0.87 .0098 0.57 0.37 0.88 .0118
 High 167 14.37 0.33 0.20 0.56 <.0001 0.36 0.21 0.63 .0003
Income
 Low 330 25.15 1.00 1.00 1.00 ref 1.00 1.00 1.00 ref
 Moderate 144 24.31 0.96 0.61 1.51 .8447 1.24 0.76 2.01 .3849
 High 72 15.28 0.54 0.27 1.07 .0764 0.83 0.40 1.72 .6160
 No answer 41 24.39 0.96 0.45 2.04 .9155 0.93 0.43 2.02 .8496
Strength of urges to smokec
 0—no urge 21 28.57 1.08 0.90 1.30 .4192 1.05 0.87 1.28 .602
 1 61 26.23
 2 267 22.10
 3 172 21.51
 4 45 24.44
 5—strong urges 21 47.62
Motivation to stop smoking
 No motivation to stop in next 
3 months
427 25.53 1.00 1.00 1.00 ref 1.00 1.00 1.00 ref
 Motivation to stop in next 3 months 160 18.75 0.67 0.43 1.06 .0868 0.75 0.47 1.21 .2343
Any e-cigarette use
 No e-cigarette use 328 25.61 1.00 1.00 1.00 ref 1.00 1.00 1.00 ref
 E-cigarette use 259 21.24 0.78 0.53 1.15 .2163 0.81 0.54 1.22 .3052
LCI = lower 95% confidence interval; UCI = upper 95% confidence interval.
aBold indicates significant at P < .05.
bOR = odds ratio.
cContinuous variable.
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and quitting smoking are correlated. However, the analyses were 
adjusted for a variety of sociodemographic and smoker characteris-
tics at baseline. Whether the e-cigarette was used with nicotine was 
not measured, nor was duration of use, however, we did adjust for 
use of e-cigarettes at baseline.
Despite limitations, this study has several strengths, a sample that 
was drawn from the general population in Britain, adjustment for 
factors that predict quitting at baseline in models predicting quitting, 
and detailed information on type of e-cigarette used that was cross 
checked with brand and model. Additionally, as previously stated, 
several variables that have been previously demonstrated to predict 
quitting also predicted quitting in this study.
Future research using longitudinal studies and randomized control 
trials should further investigate the association between e-cigarette use 
and smoking behavior, that is, whether they promote or deter smoking 
cessation. Such studies should consider frequency of use, type of e-ciga-
rette, whether used during a quit attempt, after quitting, for temporary 
abstinence/cutting down, duration of use, and nicotine content. Future 
research should also consider the role of user preferences. Indeed, the 
current study demonstrates that the users of tanks versus cigalikes differ. 
It will also be important to understand why type of e-cigarette used is 
associated with smoking cessation; for example, effectiveness for smoking 
cessation may depend on differences in nicotine delivery, relieving urges to 
smoke, user satisfaction, psycho-social influences (eg, norms), bio-behav-
ioral feedback, and/or marketing, including promotion and price.
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Table 3. E-cigarette Use, Product Type, and Quit Smoking at Follow-up, N = 1643a
Variable N % Quit smoking ORb LCI UCI P
Baseline
 Gender
  Male 931 11.39 1.00 1.00 1.00 ref
  Female 712 12.78 1.22 0.89 1.67 .2167
 Age
  18–24 164 12.20 1.00 1.00 1.00 ref
  25–39 459 15.03 1.33 0.76 2.33 .3171
  40–54 528 11.55 0.97 0.55 1.69 .907
  ≥55 492 9.55 0.91 0.51 1.62 .7434
 Education
  Low 571 11.73 1.00 1.00 1.00 ref
  Medium 641 12.48 1.04 0.73 1.50 .8228
  High 431 11.60 0.82 0.54 1.26 .3633
 Income
  Low 938 10.23 1.00 1.00 1.00 ref
  Medium 379 13.72 1.21 0.83 1.78 .319
  High 180 16.11 1.63 1.00 2.66 .0483
  No answer 146 13.70 1.40 0.82 2.39 .2201
 Motivation to stop smoking
  No motivation to stop in next 
  3 months
1288 9.7 1.00 1.00 1.00 ref
  Motivation to stop in next  
  3 months
355 20.28 2.54 1.81 3.56 <.0001
 Strength of urges to smokec
  0—no urge 126 23.81 0.77 0.66 0.89 .0004
  1 212 16.04
  2 764 10.47
  3 387 9.82
  4 105 8.57
  5—strong urges 49 12.24
 Any e-cigarette use at baseline
  No e-cigarette use 1295 12.74 1.00 1.00 1.00 ref
  E-cigarette use 348 9.20 0.83 0.52 1.30 .4067
Follow-up
 E-cigarette type and frequency of use at follow-up
  No e-cigarette use 1056 13.45 1.00 1.00 1.00 ref
  Non-daily cigalike 325 5.23 0.35 0.20 0.60 .0002
  Daily cigalike 123 10.57 0.74 0.39 1.42 .3644
  Non-daily tank 70 8.57 0.70 0.29 1.68 .4216
  Daily tank 69 27.54 2.69 1.48 4.89 .0012
LCI = lower 95% confidence interval; UCI = upper 95% confidence interval.
aBold indicates significant at P < .05.
bOR = odds ratio.
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